参考文献/References:
[1] Besser LM,Alosco ML,Ramirez GL,et al.Late-Life vascular risk factors and alzheimer disease neuropathology in individuals with normal cognition[J].J Neuropathol Exp Neurol,2016,75(10):955-962.
[2] Bonham LW,Desikan RS,Yokoyama JS.The relationship between complement factor C3,APOE epsilon4,amyloid and tau in Alzheimer's disease[J].Acta Neuropathol Commun,2016,4(1):65.
[3] Dibattista AM,Heinsinger NM,William RG.Alzheimer's disease genetic risk factor APOE-epsilon4 also affects normal brain function[Z],2016.
[4] Stojakovic T,Scharnagl H,Marz W.Crossroads between alzheimer's disease and atherosclerosis[J].Semin Vasc Med,2004,4(3):279-285.
[5] Galvan V,Hart MJ.Vascular mTOR-dependent mechanisms linking the control of aging to Alzheimer's disease[J].Biochimica et Biophysica Acta-Molecular Basis of Disease,2016,1862(5,SI):992-1007.
[6] Meng GF,Zhong XY,Mei HK.A systematic investigation into aging related genes in brain and their relationship with alzheimer's disease[J].PLoS One,2016,11(3):e0150624.
[7] Skoog I,Gustafson D.Update on hypertension and Alzheimer's disease[J].Neurol Res,2006,28(6):605-611.
[8] Wiesmann M,Roelofs M.Van der Lugt R,heerschap a,kiliaan AJ,claassen JA:angiotensin II,hypertension,and angiotensin II receptor antagonism:roles in the behavioural and brain pathology of a mouse model of alzheimer's disease[Z],2016.
[9] Sparks DL.Coronary Artery Disease,hypertension,ApoE.And cholesterol:a Link to alzheimer's disease? [J].Ann N Y Acad Sci 1997,826:128-146.
[10] Connelly PJ,Prentice NP,Fowler KG.Hypertension,white matter change and response to cholinesterase inhibitors in Alzheimer's disease[J].Int J Geriatr Psychiatry,2005,20(7):623-628.
[11] Carnevale D,Perrotta M,Lembo G,et al.Pathophysiological links among hypertension and alzheimer's disease[J].High Blood Press Cardiovasc Prev,2016,23(1):3-7.
[12] Alosco ML,Hayes SM.Structural brain alterations in heart failure:a review of the literature and implications for risk of Alzheimer's disease[J].Heart Fail Rev,2015,20(5):561-571.
[13] Cermakova P,Eriksdotter M,Lund LH,et al.Heart failure and Alzheimer's disease[J].J Intern Med,2015,277(4):406-425.
[14] Rusanen M,Kivipelto M,Levalahti E,et al.Heart diseases and Long-Term risk of dementia and alzheimer's disease: a Population-Based CAIDE study[J].Journal of Alzheimers Disease,2014,42(1):183-191.
[15] Wolozin B,Bednar MM.Interventions for heart disease and their effects on Alzheimer's disease[J].Neurol Res,2006,28(6):630-636.
[16] De La Torre JC.How do heart disease and stroke become risk factors for Alzheimer's disease? [J].Neurol Res 2006,28(6):637-644.
[17] Minagawa H,Watanabe A,Akatsu H,et al.Jung CG et al:homocysteine,another risk factor for alzheimer disease,impairs apolipoprotein E3 function[J].J Biol Chem,2010,285(49):38382-38388.
[18] Warchol-Celinska E,Styczynska M,Prejbisz A,et al.Zdrojewski T et al:hypertension in patients with alzheimer's disease--prevalence,characteristics,and impact on clinical outcome[J].J Am Soc Hypertens,9(9):711-724.
[19] Kivipelto M,Helkala EL,Laakso MP,et al.Midlife vascular risk factors and Alzheimer's disease in later Life:longitudinal,population based study[J].BMJ,2001,322(7300):1447-1451.
[20] Luchsinger JA,Gustafson D.Type 2 diabetes,and alzheimer's disease[J].J Alzheimers Dis,2009,16(4):693-704.
[21] Solomon A,Kivipelto M,Wolozin B,et al.Midlife serum cholesterol and increased risk of Alzheimer's and vascular dementia three decades later[J].Dement Geriatr Cogn Disord,2009,28(1):75-80.
[22] van Oijen M,de Jong FJ,Witteman JC,Hofman A,Koudstaal PJ,Breteler MM: Atherosclerosis and risk for dementia[J].Ann Neurol,2007,61(5):403-410.
[22] Van Oijen M DJ,Risk FD.Atherosclerosis and risk for dementia[J].Ann Neurol, 2007,61(5):403-410.
[23] Ob RB.Vascular dementia:atherosclerosis,cognition and Alzheimer's disease[J].Curr Alzheimer Res,2011,8(4):341-344.
[24] Beach TG,Wilson JR,Li SE,et al.Sabbagh M et al:circle of willis atherosclerosis:association with alzheimer's disease,neuritic plaques and neurofibrillary tangles[J].Acta Neuropathol,2007,113(1):13-21.
[25] Dolan H,Crain B,Troncoso J,et al.Dementia,and alzheimer disease in the Baltimore longitudinal study of aging cohort[J].Ann Neurol,2010,68(2):231-240.
[26] Erlich PM,Lunetta KL,Cupples L,et al.Serum paraoxonase activity is associated with variants in the PON gene cluster and risk of Alzheimer disease[J].Neurobiol Aging,2012,33(5):e1017-e1023.
[27] An,Ozcan KS,Yuksel G,et al.Karaca M et al:altered diastolic function and aortic stiffness in alzheimer's disease[J].Clin Interv Aging,2014,9:1115-1121.
[28] Bektas O,Gunaydin ZY,Karagoz A,et al.Drug therapies and presence of coronary artery disease May affect aortic stiffness in Alzheimer's disease[J].Clin Interv Aging,2015,10:469-470.
[29] Kim TW,Song IU,Jeong DS,et al.Clinical effect of cerebrovascular atherosclerosis on cognition in Alzheimer's disease[J].Arch Gerontol Geriatr,2016,63:55-58.
[30] Kalback W,Esh C,Castano EM,et al.Richardson C et al:atherosclerosis,vascular amyloidosis and brain hypoperfusion in the pathogenesis of sporadic alzheimer's disease[J].Neurol Res,2004,26(5):525-539.
[31] Arai H.Importance of vascular aspects in Alzheimer's disease[J].Nihon Ronen Igakkai Zasshi,2006,43(4):449-452.
[32] Thal DR,Attems J,Ewers M.Spreading of amyloid,tau,and microvascular pathology in Alzheimer's disease: findings from neuropathological and neuroimaging studies[J].J Alzheimers Dis 2014,42( Suppl 4):S421-S429.
[33] Goos JD,Teunissen CE,Veerhuis R,et al.Van der flier WM:microbleeds Relate to altered amyloid-beta metabolism in alzheimer's disease[J].Neurobiol Aging,2012,33(1011):e1011-e1019.
[34] Lee S,Viqar F,Zimmerman ME,et al.Fox NC et al:white matter hyperintensities are a core feature of alzheimer's disease:evidence from the dominantly inherited alzheimer network[J].Ann Neurol,2016,79(6):929-939.
[35] Gupta A,Iadecola C.Impaired abeta clearance:a potential Link between atherosclerosis and alzheimer's disease[J].Front Aging Neurosci,2015,7:115.
[36] Fiolaki A,Tsamis KI,Milionis HJ,et al.Biomarkers of atherosclerosis and alzheimer's disease[J].Int J Neurosci,2014,124(1):1-11.
[37] Halliday MR,Rege SV,Ma QY,et al.Accelerated pericyte degeneration and blood-brain barrier breakdown in apolipoprotein E4 carriers with Alzheimer's disease[J].Journal of Cerebral Blood Flow and Metabolism,2016,36(1):216-227.
[38] Sydow A,Hochgrafe K,Konen S,et al.Age-dependent neuroinflammation and cognitive decline in a novel Ala152Thr-Tau transgenic mouse model of PSP and AD[J].Acta Neuropathol Commun,2016,4:17.
[39] Rafael H.Cerebral atherosclerosis and oxidative stress in Alzheimer's disease[J].J Alzheimers Dis,2003,5(6):479-480.
[40] Weksler ME,Goodhardt M.Do age-associated changes in'physiologic'autoantibodies contribute to infection,atherosclerosis,and Alzheimer's disease? [J].Exp Gerontol 2002,37(8/9):971-979.
[41] Hendrie HC,Hake A,Lane K,et al.Callahan C et al:statin use,incident dementia and alzheimer disease in elderly African americans[J].Ethn Dis,2015,25(3):345-354.
[42] Siegel GJ,Chauhan NB,Feinstein DL.Statin therapy is associated with reduced neuropathologic changes of Alzheimer disease[J].Neurology,2008,71(5):383.
[43] Nilsson SE,Johansson B,Takkinen S,et al.Does aspirin protect against Alzheimer's dementia?A study in a Swedish population-based sample aged>or=80 years[J].Eur J Clin Pharmacol,2003,59(4):313-319.
[44] Hattori Y,Maki T,Saito S,et al.Influence of Low-Dose aspirin on cerebral amyloid angiopathy in mice[J].Journal of Alzheimers Disease,2016,52(3):1037-1045.
[45] Thoonsen H,Richard E,Bentham P,et al.Aspirin in alzheimer's disease:increased risk of intracerebral hemorrhage:cause for concern? [J].stroke 2010,41(11):2690-2692.